Mechanism of E-cadherin redistribution in bronchial airway epithelial cells in a TDI-induced asthma model

Toxicology Letters

Volumn 220, Issue 1, 2013, Pages 8-14

  Song, Jiafu ^a   Zhao, Haijin ^a   Dong, Hangming ^a   Zhang, Dandan ^a   Zou, Mengchen ^b   Tang, Haixiong ^a   Liu, Laiyu ^a   Liang, Zhenyu ^a   Lv, Yanhua ^a   Zou, Fei ^c   Cai, Shaoxi ^a  

^a Chronic Airways Diseases Laboratory   (China)

^b FIRST MILITARY MEDICAL UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Asthma; Bronchial epithelial (HBE) cells; E cadherin; Extracellular signal regulated kinase; Toluene 2,4 diisocyanate (TDI)

Indexed keywords

DEXAMETHASONE; HUMAN SERUM ALBUMIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TOLUENE DIISOCYANATE; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; IMMUNOREACTIVITY; IN VITRO STUDY; LUNG LAVAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFLAMMATION;

ALLERGENS; ANIMALS; ASTHMA; BRONCHI; BRONCHOALVEOLAR LAVAGE FLUID; CADHERINS; CELLS, CULTURED; DEXAMETHASONE; DISEASE MODELS, ANIMAL; DRUG ANTAGONISM; EPITHELIAL CELLS; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; NEUTROPHILS; TOLUENE 2,4-DIISOCYANATE;

EID: 84877357483     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2013.03.033     Document Type: Article

References (23)

1. Balmes J., Becklake M., Blanc P., Henneberger P., Kreiss K., Mapp C., Milton D., Schwartz D., Toren K., Viegi G. American Thoracic Society statement: occupational contribution to the burden of airway disease. American Journal of Respiratory and Critical Care Medicine 2003, 167:787-797.
2. Ban M., Morel G., Langonne I., Huguet N., Pepin E., Binet S. TDI can induce respiratory allergy with Th2-dominated response in mice. Toxicology 2006, 218:39-47.
3. Chun J., Prince A. TLR2-induced calpain cleavage of epithelial junctional proteins facilitates leukocyte transmigration. Cell Host and Microbe 2009, 5:47-58.
4. Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. Journal of Immunology 1995, 154:4719-4725.
5. De Vooght V., Vanoirbeek J.A., Haenen S., Verbeken E., Nemery B., Hoet P.H. Oropharyngeal aspiration: an alternative route for challenging in a mouse model of chemical-induced asthma. Toxicology 2009, 259:84-89.
6. Evans S.M., Blyth D.I., Wong T., Sanjar S., West M.R. Decreased distribution of lung epithelial junction proteins after intratracheal antigen or lipopolysaccharide challenge: correlation with neutrophil influx and levels of BALF sE-cadherin. American Journal of Respiratory Cell and Molecular Biology 2002, 27:446-454.
7. Heijink I.H., Kies P.M., Kauffman H.F., Postma D.S., van Oosterhout A.J.M., Vellenga E. Down-regulation of E-cadherin in human bronchial epithelial cells leads to epidermal growth factor receptor-dependent Th2 cell-promoting activity. The Journal of Immunology 2007, 178:7678-7685.
8. Heijink I.H., van Oosterhout A., Kapus A. Epidermal growth factor receptor signalling contributes to house dust mite-induced epithelial barrier dysfunction. European Respiratory Journal 2010, 36:1016-1026.
9. Ito K., Herbert C., Siegle J.S., Vuppusetty C., Hansbro N., Thomas P.S., Foster P.S., Barnes P.J., Kumar R.K. Steroid-resistant neutrophilic inflammation in a mouse model of an acute exacerbation of asthma. American Journal of Respiratory Cell and Molecular Biology 2008, 39:543-550.
10. Lange R.W., Lantz R.C., Stolz D.B., Watkins S.C., Sundareshan P., Lemus R., Karol M.H. Toluene diisocyanate colocalizes with tubulin on cilia of differentiated human airway epithelial cells. Toxicological Sciences 1999, 50:64-71.
11. Lee Y.M., Kim H.A., Park H.S., Lee S.K., Nahm D.H. Exposure to toluene diisocyanate (TDI) induces IL-8 production from bronchial epithelial cells: effect of pro-inflammatory cytokines. Journal of Korean Medical Science 2003, 18:809-812.
12. Lomask M. Further exploration of the Penh parameter. Experimental and Toxicologic Pathology 2006, 57(Suppl. 2):13-20.
13. Maestrelli P., Boschetto P., Fabbri L.M., Mapp C.E. Mechanisms of occupational asthma. Journal of Allergy and Clinical Immunology 2009, 123:531-542.
14. Nawijn M.C., Hackett T.L., Postma D.S., van Oosterhout A.J.M., Heijink I.H. E-cadherin: gatekeeper of airway mucosa and allergic sensitization. Trends in Immunology 2011, 32:248-255.
15. Ogawa H., Inoue S., Ogushi F., Ogura H., Nakamura Y. Toluene diisocyanate (TDI) induces production of inflammatory cytokines and chemokines by bronchial epithelial cells via the epidermal growth factor receptor and p38 mitogen-activated protein kinase pathways. Experimental Lung Research 2006, 32:245-262.
16. Sekiyama A., Gon Y., Terakado M., Takeshita I., Kozu Y., Maruoka S., Matsumoto K., Hashimoto S. Glucocorticoids enhance airway epithelial barrier integrity. International Immunopharmacology 2012, 12:350-357.
17. Solanas G., Porta-de-la-Riva M., Agustí C., Casagolda D., Sánchez-Aguilera F., Larriba M.J., Pons F., Peiró S., Escrivà M., Muñoz A. E-cadherin controls β-catenin and NF-κB transcriptional activity in mesenchymal gene expression. Journal of Cell Science 2008, 121:2224-2234.
18. Son M., Lee M., Kim Y.T., Youn J.K., Park H. Heterogeneity of IgE response to TDI-HSA conjugates by ELISA in toluene diisocyanate (TDI)-induced occupational asthma (OA) patients. Journal of Korean Medical Science 1998, 13:147-152.
19. Tarkowski M., Vanoirbeek J.A., Vanhooren H.M., De Vooght V., Mercier C.M., Ceuppens J., Nemery B., Hoet P.H. Immunological determinants of ventilatory changes induced in mice by dermal sensitization and respiratory challenge with toluene diisocyanate. American Journal of Physiology: Lung Cellular and Molecular Physiology 2007, 292:L207-L214.
20. Tunggal J.A., Helfrich I., Schmitz A., Schwarz H., Günzel D., Fromm M., Kemler R., Krieg T., Niessen C.M. E-cadherin is essential for in vivo epidermal barrier function by regulating tight junctions. The EMBO Journal 2005, 24:1146-1156.
21. Wan H., Winton H.L., Soeller C., Stewart G.A., Thompson P.J., Gruenert D.C., Cannell M.B., Garrod D.R., Robinson C. Tight junction properties of the immortalized human bronchial epithelial cell lines Calu-3 and 16HBE14o. European Respiratory Journal 2000, 15:1058-1068.
22. Xiao C., Puddicombe S.M., Field S., Haywood J., Broughton-Head V., Puxeddu I., Haitchi H.M., Vernon-Wilson E., Sammut D., Bedke N., Cremin C., Sones J., Djukanovic R., Howarth P.H., Collins J.E., Holgate S.T., Monk P., Davies D.E. Defective epithelial barrier function in asthma. Journal of Allergy and Clinical Immunology 2011, 128:549-556.
23. Zhao H., Peng H., Cai S.X., Li W., Zou F., Tong W. Toluene diisocyanate enhances human bronchial epithelial cells' permeability partly through the vascular endothelial growth factor pathway. Clinical and Experimental Allergy 2009, 39:1532-1539.